JASON CLAY: Open Payments
NPI 1912570292 · WARSAW, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,465 in 89 payments from 23 companies in 2025. Trend: 2023 $614 · 2024 $788 · 2025 $1,465
Food & beverage: $1,465
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $269 |
| Axsome Therapeutics, Inc. | 17 | $157 |
| Inspire Medical Systems, Inc. | 3 | $121 |
| Vanda Pharmaceuticals Inc. | 3 | $113 |
| Lilly USA, LLC | 6 | $110 |
| Novo Nordisk Inc | 6 | $100 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Janssen Pharmaceuticals, Inc | 3 | $56 |
| Lundbeck LLC | 2 | $48 |
Products named: Auvelity, VRAYLAR, REXULTI, INSPIRE, FANAPT, MOUNJARO, UBRELVY, JARDIANCE.
Industry payments across IN — which companies pay providers there.
